Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Lung Cancer

Free Subscription Articles published in Eur J Cardiothorac Surg Retrieve available abstracts of 131 articles: HTML format

Single Articles

August 2022
1. ZHOU H, Zhu Y, Yan H, Guo H, et al
   What is the proper treatment for visceral pleural invasion in non-small cell lung cancer patients?
   Eur J Cardiothorac Surg. 2022 Aug 4. pii: 6655689. doi: 10.1093.
   PubMed    
   
   
   
2. HUANG L, Frandsen MN, Kehlet H, Petersen RH, et al
   Early and late readmissions after enhanced recovery thoracoscopic lobectomy.
   Eur J Cardiothorac Surg. 2022;62.
   PubMed     Abstract available
   
   
   July 2022
3. BOLUKBAS S, Baldes N, Hoda MA, Eberlein M, et al
   Multimodality treatment of malignant pleural mesothelioma: evolving patient selection criteria using scores.
   Eur J Cardiothorac Surg. 2022;62.
   PubMed    
   
   
   
4. GREB D, Hebeisen M, Matter A, Opitz I, et al
   Prospective validation and extension of the Multimodality Prognostic Score for the treatment allocation of pleural mesothelioma patients.
   Eur J Cardiothorac Surg. 2022;62.
   PubMed     Abstract available
   
   
   
5. SCHLACHTENBERGER G, Doerr F, Menghesha H, Heldwein MB, et al
   Pulmonary metastasectomy for metastatic head and neck cancer prolongs survival significantly compared to non-surgical therapy.
   Eur J Cardiothorac Surg. 2022;62.
   PubMed     Abstract available
   
   
   
6. YANG Z, Wang Y, Chen Y, Qian F, et al
   Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management.
   Eur J Cardiothorac Surg. 2022;62.
   PubMed     Abstract available
   
   
   
7. KAMIGAICHI A, Aokage K, Katsumata S, Ishii G, et al
   Prognostic Impact of Examined Mediastinal Lymph Node Count in Clinical N0 Non-Small Cell Lung Cancer.
   Eur J Cardiothorac Surg. 2022 Jul 4. pii: 6628585. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2022
8. PONS A, De Sousa P, Proli C, Booth SA, et al
   Impact of society and national guidelines on patient selection for lung cancer surgery in the United Kingdom.
   Eur J Cardiothorac Surg. 2022 Jun 29. pii: 6619559. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. DE RUITER JC, Smit EF, van der Noort V, Hartemink KJ, et al
   Reply to Peng et al.
   Eur J Cardiothorac Surg. 2022;62.
   PubMed    
   
   
   
10. WILLIAMS NR, Patrick H, Fiorentino F, Allen A, et al
    Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) randomized controlled trial: a systematic review of published responses.
    Eur J Cardiothorac Surg. 2022;62.
    PubMed     Abstract available
    
    
    
11. TAKAMORI S, Oizumi H, Suzuki J, Watanabe H, et al
    Thoracoscopic anatomical individual basilar segmentectomy.
    Eur J Cardiothorac Surg. 2022;62.
    PubMed     Abstract available
    
    
    
12. SOH J, Toyooka S, Shintani Y, Okami J, et al
    Limited resection for stage IA radiologically invasive lung cancer: a real-world nationwide database study.
    Eur J Cardiothorac Surg. 2022 Jun 9. pii: 6604739. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2022
13. PENG L, Deng HY, Wang Y
    Surgery should still remain the prior option for treating operable early-stage non-small cell lung cancer.
    Eur J Cardiothorac Surg. 2022 May 28. pii: 6594489. doi: 10.1093.
    PubMed    
    
    
    
14. DAFFRE E, Prieto M, Maiolino E, Alifano M, et al
    Spreading through airspaces: should its existence play a role in thinking about lung metastases?
    Eur J Cardiothorac Surg. 2022;61:1249-1250.
    PubMed    
    
    
    
15. IGAI H, Matsuura N, Kamiyoshihara M
    Infrared thoracoscopic pulmonary segmentectomy with intravenous indocyanine green administration using preoperative simulation.
    Eur J Cardiothorac Surg. 2022;61:1443-1445.
    PubMed     Abstract available
    
    
    
16. MA Y, Zhang Y, Li H, Li J, et al
    Spread through air spaces is a common phenomenon of pulmonary metastasized tumours regardless of origins.
    Eur J Cardiothorac Surg. 2022;61:1242-1248.
    PubMed     Abstract available
    
    
    
17. IGAI H, Matsuura N, Kamiyoshihara M
    Invited commentary on: The usefulness of the nomogram to predict tumor spread through air spaces (STAS) in patients with clinical stage I non-small cell lung cancer preoperatively.
    Eur J Cardiothorac Surg. 2022 May 13. pii: 6585338. doi: 10.1093.
    PubMed    
    
    
    
18. MERCIER O
    VATS vs. Open Thoracotomy for lung cancer resection: is the game still running?
    Eur J Cardiothorac Surg. 2022 May 11. pii: 6584011. doi: 10.1093.
    PubMed    
    
    
    
19. MA Z, Wang S, Zhu H, Li Y, et al
    Comprehensive Investigation of Lung Cancer Associated with Cystic Airspaces: Predictive Value of Morphology.
    Eur J Cardiothorac Surg. 2022 May 4. pii: 6580206. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. VARELA G
    Do not try to run before you can walk.
    Eur J Cardiothorac Surg. 2022;61:1030.
    PubMed    
    
    
    April 2022
21. MATSUO S, Kanauchi N, Satou K, Uchida T, et al
    A surgical case: patient with left lower lobe lung cancer with a common trunk in the inferior pulmonary vein.
    Eur J Cardiothorac Surg. 2022 Apr 20. pii: 6571146. doi: 10.1093.
    PubMed    
    
    
    
22. HEALY DG
    The visceral pleura, lung cancer and lymphatic spread.
    Eur J Cardiothorac Surg. 2022 Apr 19. pii: 6570167. doi: 10.1093.
    PubMed    
    
    
    
23. WANG YF, Deng HY, Huang W, Zhou Q, et al
    Segmentectomy for early-stage non-small-cell lung cancer with invasive characteristics: the definitions of invasiveness and feasibility of segmentectomy.
    Eur J Cardiothorac Surg. 2022 Apr 9. pii: 6565839. doi: 10.1093.
    PubMed    
    
    
    
24. DING Y, Chen Y, Wen H, Li J, et al
    Pretreatment prediction of tumour spread through air spaces in clinical stage I non-small cell lung cancer.
    Eur J Cardiothorac Surg. 2022 Apr 6. pii: 6564227. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2022
25. DE RUITER JC, van Diessen JNA, Smit EF, van der Noort V, et al
    Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
    Eur J Cardiothorac Surg. 2022 Mar 28. pii: 6554916. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. KUDO Y, Shimada Y, Matsubayashi J, Kitamura Y, et al
    Artificial intelligence analysis of three-dimensional imaging data derives factors associated with postoperative recurrence in patients with radiologically solid-predominant small-sized lung cancers.
    Eur J Cardiothorac Surg. 2022;61:751-760.
    PubMed     Abstract available
    
    
    
27. HATTORI A, Matsunaga T, Fukui M, Takamochi K, et al
    Prognosis of epidermal growth factor receptor-mutated stage I lung adenocarcinoma with radiologically solid features.
    Eur J Cardiothorac Surg. 2022;61:769-777.
    PubMed     Abstract available
    
    
    
28. YAMAGUCHI H, Sato M, Yamamoto K, Ueda K, et al
    Virtual-assisted lung mapping in sublobar resection of small pulmonary nodules, long-term results.
    Eur J Cardiothorac Surg. 2022;61:761-768.
    PubMed     Abstract available
    
    
    
29. KAMIGAICHI A, Tsutani Y, Mimae T, Miyata Y, et al
    The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2022 Mar 16. pii: 6549206. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. KADOMATSU Y, Sugiyama T, Sato K, Nakanishi K, et al
    Relationship of smoking cessation period with the incidence of complications in lung cancer surgery.
    Eur J Cardiothorac Surg. 2022 Mar 10. pii: 6546233. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. KAPETANAKIS EI, Tomos IP, Schizas D, Caimmi PP, et al
    Seeking Aristotle's 'golden mean' in lung cancer resection surgery.
    Eur J Cardiothorac Surg. 2022 Mar 9. pii: 6545819. doi: 10.1093.
    PubMed    
    
    
    February 2022
32. RECUERO-DIAZ JL, Royo-Crespo I, Gomez de-Antonio D, Call S, et al
    Treatment and intention-to-treat propensity score analysis to evaluate the impact of video-assisted thoracic surgery on 90-day mortality after anatomical resection for lung cancer.
    Eur J Cardiothorac Surg. 2022 Feb 25. pii: 6537078. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. KAGIMOTO A, Tsutani Y, Shimada Y, Mimae T, et al
    Oncological outcome of segmentectomy for early-stage non-small-cell lung cancer with invasive characteristics: a multicentre study.
    Eur J Cardiothorac Surg. 2022 Feb 12. pii: 6527517. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. RABINEL P, Verge R, Cazaux M, Mazzoni L, et al
    Predictive factors and prognosis of microscopic residual disease in non-small-cell lung cancer surgery.
    Eur J Cardiothorac Surg. 2022 Feb 11. pii: 6527003. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2022
35. CHAN JWY, Lau RWH, Ng CSH
    Splitting hairs or not: importance of N2 subclassification after neoadjuvant treatment and surgery.
    Eur J Cardiothorac Surg. 2022;61:277-278.
    PubMed    
    
    
    
36. HATTORI A, Matsunaga T, Fukui M, Takamochi K, et al
    Prognostic influence of a ground-glass opacity component in hypermetabolic lung adenocarcinoma.
    Eur J Cardiothorac Surg. 2022;61:249-256.
    PubMed     Abstract available
    
    
    
37. GOMEZ-HERNANDEZ MT, Fuentes MG, Novoa NM, Rodriguez I, et al
    The robotic surgery learning curve of a surgeon experienced in video-assisted thoracoscopic surgery compared with his own video-assisted thoracoscopic surgery learning curve for anatomical lung resections.
    Eur J Cardiothorac Surg. 2022;61:289-296.
    PubMed     Abstract available
    
    
    
38. ZHANG C, Li J, Sun H, Liu H, et al
    An aberrant anterior ascending segmental pulmonary artery (A3aii) in a patient with lung cancer.
    Eur J Cardiothorac Surg. 2022 Jan 8. pii: 6501291. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2021
39. PETERSEN RH
    Is complex segmentectomy safe?
    Eur J Cardiothorac Surg. 2021;61:108-109.
    PubMed    
    
    
    
40. HATTORI A, Takamochi K, Shiono S, Tsuboi M, et al
    Multicentre prospective observational study for pulmonary vein stump thrombus after anatomical lung resections.
    Eur J Cardiothorac Surg. 2021;61:92-99.
    PubMed     Abstract available
    
    
    
41. OKUBO Y, Yoshida Y, Yotsukura M, Nakagawa K, et al
    Complex segmentectomy is not a complex procedure relative to simple segmentectomy.
    Eur J Cardiothorac Surg. 2021;61:100-107.
    PubMed     Abstract available
    
    
    November 2021
42. DRAWBERT HE, Hey MT, Tarrazzi F, Block M, et al
    Early discharge on postoperative day 1 following lobectomy for stage I non-small-cell lung cancer is safe in high-volume surgical centres: a national cancer database analysis.
    Eur J Cardiothorac Surg. 2021 Nov 29. pii: 6445266. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. WIGHTMAN SC, Lee JY, Ding L, Atay SM, et al
    Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
    Eur J Cardiothorac Surg. 2021 Nov 22. pii: 6433261. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. WANG Y, Zhong C, Fang W
    Thoracoscopic segmentectomy for early-stage non-small cell lung cancer: are we doing the right thing for our patients?
    Eur J Cardiothorac Surg. 2021 Nov 11. pii: 6425615. doi: 10.1093.
    PubMed    
    
    
    
45. MATSUGUMA H, Hasumi K, Wakamatsu I, Nakahara R, et al
    Segmentectomy versus lobectomy for solid predominant cN0 lung cancer considering Deauville score.
    Eur J Cardiothorac Surg. 2021 Nov 11. pii: 6425616. doi: 10.1093.
    PubMed    
    
    
    
46. GRYSZKO GM, Cackowski MM, Zbytniewski M, Woznica K, et al
    The impact of left lower paratracheal (4L) lymph node dissection on survival in patients with surgically treated left-sided NSCLC.
    Eur J Cardiothorac Surg. 2021;60:1201-1209.
    PubMed     Abstract available
    
    
    
47. DENG C, Zhang Y, Fu F, Ma X, et al
    Genetic-pathological prediction for timing and site-specific recurrence pattern in resected lung adenocarcinoma.
    Eur J Cardiothorac Surg. 2021;60:1223-1231.
    PubMed     Abstract available
    
    
    
48. CABANERO A, Cavestany C, Fra S, Munoz G, et al
    Mediastinal lymph node dissection: punishment or discipline?
    Eur J Cardiothorac Surg. 2021;60:1242-1243.
    PubMed    
    
    
    October 2021
49. ISAKA T, Ito H, Nakayama H, Yokose T, et al
    Impact of the initial site of recurrence on prognosis after curative surgery for primary lung cancer.
    Eur J Cardiothorac Surg. 2021 Oct 23. pii: 6408981. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. XU L, Yan HJ, Tian D
    Prediction model of lymph node metastases for lung adenocarcinoma: increased applicability of this modeldouble dagger.
    Eur J Cardiothorac Surg. 2021;60:1007-1008.
    PubMed    
    
    
    
51. KAGIMOTO A, Tsutani Y, Mimae T, Miyata Y, et al
    Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography.
    Eur J Cardiothorac Surg. 2021 Oct 14. pii: 6396284. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. DELL'AMORE A, Lomangino I, Cannone G, Terzi S, et al
    Comparison of operative and postoperative characteristics and outcomes between thoracoscopic segmentectomy and lobectomy for non-small-cell lung cancer: a propensity score matching study from the Italian VATS Group Registry.
    Eur J Cardiothorac Surg. 2021 Oct 13. pii: 6395268. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
53. GOSSOT D
    Lobar or sublobar resection for early-stage lung cancer: at the crossroads.
    Eur J Cardiothorac Surg. 2021 Sep 21. pii: 6373496. doi: 10.1093.
    PubMed    
    
    
    
54. TANE S, Nishikubo M, Kitazume M, Fujibayashi Y, et al
    Cluster analysis of emphysema for predicting pulmonary complications after thoracoscopic lobectomy.
    Eur J Cardiothorac Surg. 2021;60:607-613.
    PubMed     Abstract available
    
    
    August 2021
55. MENNECIER B, Olland A, Mascaux C, Falcoz PE, et al
    Re: Two centres' experience with lung cancer resection in patients with advanced non-small-cell lung cancer following treatment with immune checkpoint inhibitors: safety and clinical outcomes.
    Eur J Cardiothorac Surg. 2021 Aug 26. pii: 6357858. doi: 10.1093.
    PubMed    
    
    
    
56. HOEIJMAKERS F, Hartemink KJ, Verhagen AF, Steup WH, et al
    Variation in incidence, prevention and treatment of persistent air leak after lung cancer surgery.
    Eur J Cardiothorac Surg. 2021 Aug 19. pii: 6354830. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. FALCOZ PE
    The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
    Eur J Cardiothorac Surg. 2021 Aug 11. pii: 6348064. doi: 10.1093.
    PubMed    
    
    
    
58. LUCCHI M, Aprile V
    Not one less, the role of 4L in left-sided lung cancer: the message from the Polish experience.
    Eur J Cardiothorac Surg. 2021 Aug 11. pii: 6348067. doi: 10.1093.
    PubMed    
    
    
    
59. STAMATIS G, Muller S, Weinreich G, Schwarz B, et al
    Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment.
    Eur J Cardiothorac Surg. 2021 Aug 9. pii: 6345854. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. MERCIER O, Barlesi F
    Precision follow-up for resected non-small-cell lung cancer: is it ready for prime time?
    Eur J Cardiothorac Surg. 2021 Aug 4. pii: 6339783. doi: 10.1093.
    PubMed    
    
    
    
61. HELMINEN O, Soderstrom J, Andersen H, Sihvo E, et al
    How often segmentectomy is feasible in lung cancer surgery: a population-based evaluation.
    Eur J Cardiothorac Surg. 2021 Aug 4. pii: 6339790. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2021
62. BEATTIE R, Furrer K, Dolan DP, Curioni-Fontecedro A, et al
    Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes.
    Eur J Cardiothorac Surg. 2021 Jul 31. pii: 6332634. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. XU ZJ, Lin YD
    Reply to Zhang et al.
    Eur J Cardiothorac Surg. 2021;60:440.
    PubMed    
    
    
    
64. KITAHARA H, Shoji F, Akamine T, Kinoshita F, et al
    Preoperative prognostic nutritional index level is associated with tumour-infiltrating lymphocyte status in patients with surgically resected lung squamous cell carcinoma.
    Eur J Cardiothorac Surg. 2021;60:393-401.
    PubMed     Abstract available
    
    
    
65. JONES DR
    Neoadjuvant immunochemotherapy in surgically resectable non-small-cell lung cancer: surgical expertise required.
    Eur J Cardiothorac Surg. 2021;60:88-90.
    PubMed    
    
    
    
66. BERTOLACCINI L, Spaggiari L
    The land of the Lotus-eaters in the COVID-19 epidemic.
    Eur J Cardiothorac Surg. 2021;60:1-2.
    PubMed    
    
    
    
67. GOOSEMAN MR, Falcoz PE, Decaluwe H, Szanto Z, et al
    Morbidity and mortality of lung resection candidates defined by the American College of Chest Physicians as 'moderate risk': an analysis from the European Society of Thoracic Surgeons database.
    Eur J Cardiothorac Surg. 2021;60:91-97.
    PubMed     Abstract available
    
    
    
68. AOKAGE K, Suzuki K, Wakabayashi M, Mizutani T, et al
    Predicting pathological lymph node status in clinical stage IA peripheral lung adenocarcinoma.
    Eur J Cardiothorac Surg. 2021;60:64-71.
    PubMed     Abstract available
    
    
    
69. CHENESSEAU J, Mitilian D, Sharma G, Mussot S, et al
    Superior vena cava prosthetic replacement for non-small cell lung cancer: is it worthwhile?
    Eur J Cardiothorac Surg. 2021 Jul 1. pii: 6312872. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. YANG H, Mei T
    The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
    Eur J Cardiothorac Surg. 2021 Jul 1. pii: 6311990. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2021
71. NOJIRI T, Inoue M, Maeda H, Takeuchi Y, et al
    Retraction to 'Low-dose human atrial natriuretic peptide for the prevention of postoperative cardiopulmonary complications in chronic obstructive pulmonary disease patients undergoing lung cancer surgery'.
    Eur J Cardiothorac Surg. 2021;59:1352.
    PubMed    
    
    
    
72. MARIANI AW, Vallilo CC, de Albuquerque ALP, Salge JM, et al
    Preoperative evaluation for lung resection in patients with bronchiectasis: should we rely on standard lung function evaluation?
    Eur J Cardiothorac Surg. 2021;59:1272-1278.
    PubMed     Abstract available
    
    
    
73. ZHAO M, Deng J, Wang T, Li Y, et al
    Impact of computed tomography window settings on clinical T classifications and prognostic evaluation of patients with subsolid nodules.
    Eur J Cardiothorac Surg. 2021;59:1295-1303.
    PubMed     Abstract available
    
    
    
74. FALCOZ PE, Olland A, Charloux A
    Does functional evaluation before lung cancer surgery need reappraisal?
    Eur J Cardiothorac Surg. 2021 Jun 11. pii: 6296136. doi: 10.1093.
    PubMed    
    
    
    May 2021
75. XIE D, Zhong Y, Deng J, She Y, et al
    Comparison of uniportal video-assisted thoracoscopic versus thoracotomy bronchial sleeve lobectomy with pulmonary arterioplasty for centrally located non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2021;59:978-986.
    PubMed     Abstract available
    
    
    
76. SHEN H, Wang X, Nie Y, Zhang K, et al
    Minimally invasive surgery versus thoracotomy for resectable stage II and III non-small-cell lung cancers: a systematic review and meta-analysis.
    Eur J Cardiothorac Surg. 2021;59:940-950.
    PubMed     Abstract available
    
    
    
77. GONZALEZ M, Brunelli A, Szanto Z, Passani S, et al
    Report from the European Society of Thoracic Surgeons database 2019: current surgical practice and perioperative outcomes of pulmonary metastasectomy.
    Eur J Cardiothorac Surg. 2021;59:996-1003.
    PubMed     Abstract available
    
    
    April 2021
78. KAMIGAICHI A, Tsutani Y, Okada M
    Reply to Zhang et al.
    Eur J Cardiothorac Surg. 2021;59:928.
    PubMed    
    
    
    
79. CASIRAGHI M, Spaggiari L
    Reply to Lampridis.
    Eur J Cardiothorac Surg. 2021;59:926-927.
    PubMed    
    
    
    
80. NAKAGAWA K
    Reply to Ding et al.
    Eur J Cardiothorac Surg. 2021;59:925-926.
    PubMed    
    
    
    
81. KANZAKI R, Nagoya A, Kanou T, Ose N, et al
    Risk factors for non-cancer death after surgery in patients with stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2021;59:633-640.
    PubMed     Abstract available
    
    
    
82. VAN RAEMDONCK D, Treasure T, Van Cutsem E, Macbeth F, et al
    Pulmonary Metastasectomy in Colorectal Cancer: has the randomized controlled trial brought enough reliable evidence to convince believers in metastasectomy to reconsider their oncological practice?
    Eur J Cardiothorac Surg. 2021;59:517-521.
    PubMed    
    
    
    
83. WANG Z, Yang H, Hao X, Zhou J, et al
    Prognostic significance of the N1 classification pattern: a meta-analysis of different subclassification methods.
    Eur J Cardiothorac Surg. 2021;59:545-553.
    PubMed     Abstract available
    
    
    
84. XIE D, Wu J, Hu X, Gonzalez-Rivas D, et al
    Uniportal versus multiportal video-assisted thoracoscopic surgery does not compromise the outcome of segmentectomy.
    Eur J Cardiothorac Surg. 2021;59:650-657.
    PubMed     Abstract available
    
    
    
85. ZHONG Y, Xu Y, Deng J, Wang T, et al
    Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma.
    Eur J Cardiothorac Surg. 2021;59:624-632.
    PubMed     Abstract available
    
    
    March 2021
86. ROMERO ROMAN A, Campo-Canaveral de la Cruz JL, Macia I, Escobar Campuzano I, et al
    Outcomes of surgical resection after neoadjuvant chemoimmunotherapy in locally advanced stage IIIA non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2021 Mar 1. pii: 6154485. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2021
87. PARK S, Kim HJ, Park IK, Kim YT, et al
    Stereotactic ablative radiotherapy versus surgery in older patients with stage I lung cancer.
    Eur J Cardiothorac Surg. 2021 Feb 28. pii: 6154725. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. TING YC, Chuang LC, Hsu PK
    Primary lung cancer in the azygos lobe.
    Eur J Cardiothorac Surg. 2021 Feb 24. pii: 6148899. doi: 10.1093.
    PubMed    
    
    
    
89. THOMAS PA
    Development of radiomics models to predict lymph node metastasis and de-escalated non-small-cell lung cancer surgery: a word of caution.
    Eur J Cardiothorac Surg. 2021 Feb 1. pii: 6125357. doi: 10.1093.
    PubMed    
    
    
    January 2021
90. PETERSEN RH, Huang L, Kehlet H
    Guidelines for enhanced recovery after lung surgery: need for re-analysis.
    Eur J Cardiothorac Surg. 2021;59:291-292.
    PubMed    
    
    
    
91. WALLER DA, Opitz I, Bueno R, Van Schil P, et al
    Divided by an ocean of water but united in an ocean of uncertainty: a transatlantic review of mesothelioma surgery guidelines.
    Eur J Cardiothorac Surg. 2021;59:8-11.
    PubMed    
    
    
    December 2020
92. ABID W, Seguin-Givelet A, Brian E, Grigoroiu M, et al
    Second pulmonary resection for a second primary lung cancer: analysis of morbidity and survival.
    Eur J Cardiothorac Surg. 2020 Dec 24. pii: 6046581. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. WU H, Jin R, Yang S, Park BJ, et al
    Long-term and short-term outcomes of robot- versus video-assisted anatomic lung resection in lung cancer: a systematic review and meta-analysis.
    Eur J Cardiothorac Surg. 2020 Dec 23. pii: 6046142. doi: 10.1093.
    PubMed     Abstract available
    
    
    
94. BAIG MZ, Razi SS, Stroever S, Weber JF, et al
    Anatomic resection has superior long-term survival compared with wedge resection for second primary lung cancer after prior lobectomy.
    Eur J Cardiothorac Surg. 2020 Dec 17. pii: 6041053. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. ZHANG X, Dong W, Zhang L
    Segmentectomy for radiologically aggressive small-sized lung cancer: one size fits all?
    Eur J Cardiothorac Surg. 2020 Dec 6. pii: 6126780. doi: 10.1093.
    PubMed    
    
    
    November 2020
96. BOUABDALLAH I, Pauly V, Viprey M, Orleans V, et al
    Unplanned readmission and survival after video-assisted thoracic surgery and open thoracotomy in patients with non-small-cell lung cancer: a 12-month nationwide cohort study.
    Eur J Cardiothorac Surg. 2020 Nov 25. pii: 6000651. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. TRICARD J, Milad D, Chermat A, Simard S, et al
    Staged management of cardiac disease and concomitant early lung cancer: a 20-year single-center experience.
    Eur J Cardiothorac Surg. 2020 Nov 19. pii: 5990294. doi: 10.1093.
    PubMed     Abstract available
    
    
    
98. LAMPRIDIS S
    The role of surgery in oligometastatic non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2020 Nov 17. pii: 5983874. doi: 10.1093.
    PubMed    
    
    
    
99. WANG Y, Qian F, Hu M, Chen Y, et al
    Clinical significance of visceral pleural and lymphovascular invasion in surgically resected adenosquamous lung cancer.
    Eur J Cardiothorac Surg. 2020 Nov 17. pii: 5983876. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. FUJIBAYASHI Y, Ogawa H, Kitazume M, Nishikubo M, et al
     Pleural invasion, epidermal growth factor receptor mutation and carcinoembryonic antigen level affect pleural lavage cytology-positive status in non-small-cell lung cancer.
     Eur J Cardiothorac Surg. 2020 Nov 16. pii: 5983731. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. DING Q, Shu J, Xu X, Chen Y, et al
     Clinical implications of the pattern of recurrence of pN2 non-small-cell lung cancer.
     Eur J Cardiothorac Surg. 2020 Nov 16. pii: 5983729. doi: 10.1093.
     PubMed    
     
     
     
102. ABUGHARARAH TZ, Jeong YH, Alabbood F, Chong Y, et al
     Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study.
     Eur J Cardiothorac Surg. 2020 Nov 5. pii: 5956254. doi: 10.1093.
     PubMed     Abstract available
     
     
     
103. CHANG SH, Zervos M, Kent A, Chachoua A, et al
     Safety of patients and providers in lung cancer surgery during the COVID-19 pandemic.
     Eur J Cardiothorac Surg. 2020 Nov 5. pii: 5956370. doi: 10.1093.
     PubMed     Abstract available
     
     
     
104. HOYOS MEJIA L, Romero Roman A, Gil Barturen M, Cordoba Pelaez MDM, et al
     Thoracic surgery during the coronavirus disease 2019 (COVID-19) pandemic in Madrid, Spain: single-centre report.
     Eur J Cardiothorac Surg. 2020;58:991-996.
     PubMed     Abstract available
     
     
     October 2020
105. POMPILI C, McLennan Battleday F, Chia WL, Chaudhuri N, et al
     Poor preoperative quality of life predicts prolonged hospital stay after VATS lobectomy for lung cancer.
     Eur J Cardiothorac Surg. 2020 Oct 15. pii: 5923779. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2020
106. KARIM HMR, Bhakta P, Esquinas AM
     An enquiry to Choi et al.'s surgical outcome and prognosis of lung cancer in patients with chronic lung disease.
     Eur J Cardiothorac Surg. 2020 Sep 28. pii: 5912545. doi: 10.1093.
     PubMed    
     
     
     
107. KAMIGAICHI A, Tsutani Y, Mimae T, Miyata Y, et al
     Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer.
     Eur J Cardiothorac Surg. 2020 Sep 7. pii: 5902140. doi: 10.1093.
     PubMed     Abstract available
     
     
     
108. NA KJ, Park S, Lee HJ, Park IK, et al
     Comparison between lung perfusion scan and single-photon emission computed tomography/computed tomography for predicting postoperative lung function after pulmonary resection in patients with borderline lung function.
     Eur J Cardiothorac Surg. 2020 Sep 3. pii: 5900864. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. GONFIOTTI A, Gatteschi L, Salvicchi A, Bongiolatti S, et al
     Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2.
     Eur J Cardiothorac Surg. 2020;58:598-604.
     PubMed     Abstract available
     
     
     
110. MA H, Zhang G
     How to treat early-stage lung adenocarcinoma based on the size of the clinical solid component?
     Eur J Cardiothorac Surg. 2020;58:662.
     PubMed    
     
     
     
111. HAN SJ, Jeon JH
     Reply to Ma and Zhang.
     Eur J Cardiothorac Surg. 2020;58:662-663.
     PubMed    
     
     
     August 2020
112. CORSINI EM, Weissferdt A, Pataer A, Zhou N, et al
     Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy.
     Eur J Cardiothorac Surg. 2020 Aug 30. pii: 5899328. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. FIORELLI S, Massullo D, Ibrahim M, Piccioni F, et al
     Perspectives in surgical and anaesthetic management of lung cancer in the era of coronavirus disease 2019 (COVID-19).
     Eur J Cardiothorac Surg. 2020 Aug 26. pii: 5897205. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. CHIAPPETTA M, Lococo F, Leuzzi G, Sperduti I, et al
     External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy.
     Eur J Cardiothorac Surg. 2020 Aug 8. pii: 5885289. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. YANG HX, Yang MZ
     Reply to Deng et al. and Zhang et al.
     Eur J Cardiothorac Surg. 2020;58:405-406.
     PubMed    
     
     
     
116. HENNON MW, DeGraaff LH, Demmy TL, Yendamuri S, et al
     Reply to Maier et al.
     Eur J Cardiothorac Surg. 2020;58:403-404.
     PubMed    
     
     
     
117. MAIER H, Ng C, Kroepfl V, Augustin F, et al
     Time to rethink the concept of nodal upstaging.
     Eur J Cardiothorac Surg. 2020;58:403.
     PubMed    
     
     
     
118. MELEK H, Ozer E, Bayram AS, Gebitekin C, et al
     Reply to Lococo et al.
     Eur J Cardiothorac Surg. 2020;58:407-408.
     PubMed    
     
     
     
119. WINCKELMANS T, Decaluwe H, De Leyn P, Van Raemdonck D, et al
     Reply to Deng and Tang.
     Eur J Cardiothorac Surg. 2020;58:406-407.
     PubMed    
     
     
     July 2020
120. NAKAGAWA K, Yoshida Y, Yotsukura M, Watanabe SI, et al
     Pattern of recurrence of pN2 non-small-cell lung cancer: should postoperative radiotherapy be reconsidered?
     Eur J Cardiothorac Surg. 2020 Jul 30. pii: 5878241. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. TEN BERGE MG, Beck N, Steup WH, Verhagen AFTM, et al
     Textbook outcome as a composite outcome measure in non-small-cell lung cancer surgery.
     Eur J Cardiothorac Surg. 2020 Jul 30. pii: 5878242. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2020
122. WU D, Liang H, Liang W, Liu H, et al
     Spontaneous ventilation video-assisted thoracoscopic surgery for patients with non-small-cell lung cancer with excess body weight.
     Eur J Cardiothorac Surg. 2020 May 23. pii: 5843501. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. ZHAO M, Deng J, She Y, Chen C, et al
     Prognostic impact of solid-part tumour volume doubling time: is it still valuable in the subgroup of patients with part-solid nodules?
     Eur J Cardiothorac Surg. 2020;57:1013.
     PubMed    
     
     
     
124. SHIMADA Y, Setojima Y, Ikeda N
     Reply to Zhao et al.
     Eur J Cardiothorac Surg. 2020;57:1013-1014.
     PubMed    
     
     
     April 2020
125. VAN DORP M, Beck N, Steup WH, Schreurs WH, et al
     Surgical treatment of pulmonary metastases in the Netherlands: data from the Dutch Lung Cancer Audit for Surgery.
     Eur J Cardiothorac Surg. 2020 Apr 13. pii: 5819620. doi: 10.1093.
     PubMed     Abstract available
     
     
     
126. BOCCHIALINI G, Lagrasta C, Madeddu D, Mazzaschi G, et al
     Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer.
     Eur J Cardiothorac Surg. 2020 Apr 8. pii: 5817917. doi: 10.1093.
     PubMed     Abstract available
     
     
     
127. HINO H, Saito T, Matsui H, Taniguchi Y, et al
     Utility of Geriatric Nutritional Risk Index in patients with lung cancer undergoing surgery.
     Eur J Cardiothorac Surg. 2020 Apr 1. pii: 5814344. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2020
128. DENG HY, Wang T, Tang X
     Should the left lower paratracheal lymph node always be dissected in patients with left-sided lung cancer?
     Eur J Cardiothorac Surg. 2020 Mar 26. pii: 5811876. doi: 10.1093.
     PubMed    
     
     
     
129. ZHANG X, Jiang Y, Zhang L
     L4 lymph node dissection in left-side operable non-small-cell lung cancer: one size fits all?
     Eur J Cardiothorac Surg. 2020 Mar 25. pii: 5811875. doi: 10.1093.
     PubMed    
     
     
     
130. HANDA Y, Tsutani Y, Okada M
     Reply to Li and Che.
     Eur J Cardiothorac Surg. 2020;57:614-615.
     PubMed    
     
     
     September 2019
131. CHEN C, Zhang X, Gu C, Wang Y, et al
     Surgery performed at night by continuously working surgeons contributes to a higher incidence of intraoperative complications in video-assisted thoracoscopic pulmonary resection: a large monocentric retrospective study.
     Eur J Cardiothorac Surg. 2019 Sep 20. pii: 5572143. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: